
Jenny Hoffmann PhD is CEO of Biorithm leveraging her expertise in strategy growth and healthtech innovation. A LinkedIn Top Voice and active CHIEF member she has previously held senior roles at W.L. Gore advancing P&L strategies and sustainable product development. Jenny’s leadership style is grounded in strategic vision and talent development with a mission to improve global health outcomes through technology.

